<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220621055238N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-08</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of yogurt and probiotic supplement on the cognitive function of patients with type 2 diabetes</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of probiotic yogurt with its supplementation on cognitive function, cortisol and serum superoxide dismutase in patients with type 2 diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>111</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64599</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Permuted block randomization with six blocks will be used for randomization. According to the determined sample size of 111, 19 blocks of six will be produced using the online site (www.sealedenvelope.com). In order to apply concealment in the randomization process, numbered envelopes containing a random sequence will be used, Blinding description: The people participating in the study, the researchers evaluating the results and the laboratory technicians will not be informed about the type of intervention until the end of the research. For this purpose, normal and probiotic yogurt packages, as well as probiotic supplement and its placebo, will be prepared similar to each other in terms of their appearance and labels, and someone other than the researcher will code them. In addition, the researcher will not know the allocation of the participants in each of the groups during the evaluation of the results.</study_design>
      <phase>3</phase>
      <hc_freetext>Type 2 diabetes mellitus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The first intervention group: they receive one probiotic supplement capsule + 200 grams of plain yogurt per day for 12 weeks. Probiotic supplement is produced by Takgene Zist Company. This probiotic product is produced from two groups of bacteria, including Lactobacilli and Bifidobacteria, with a dose of two times ten to the power of eight Colony Forming Units (CFU) per capsule, and lactose and magnesium stearate are used as carriers. Plain yogurt is low-fat and produced by Amol Doosheh Dairy Products company. Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of plain yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. The people participating in the study are emphasized to store the yogurts immediately in the refrigerator. Intervention 2: Intervention group: The second intervention group: they will receive 200 grams of probiotic yogurt + one placebo capsule per day for 12 weeks. The probiotic yogurt of the present study is low-fat yogurt and it is produced by Amol Doosheh Dairy Products company. This probiotic product is produced from two groups of bacteria, including Lactobacilli and bifidobacteria, with a dose of two times ten to the power of eight Colony Forming Units (CFU). Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of probiotic yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. Participants are emphasized to store the yogurts immediately in the refrigerator. The placebo capsule is produced by Takgene Zist Company, which contains starch and is similar to the probiotic supplement in terms of appearance, color, size, and packaging. Intervention 3: Control group: they will receive 200 grams of plain yogurt + one placebo capsule per day for 12 weeks. Plain yogurt is low-fat and produced by Amol Doosheh Dairy Products company. Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of plain yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. Participants are emphasized to store the yogurts immediately in the refrigerator. The placebo capsule is produced by Takgene Zist Company, which contains starch and is similar to the probiotic supplement in terms of appearance, color, size, and packaging.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Currently, no decision has been made regarding IDP release.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marsa Zaroudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Left side building, Safarabad  12 Avenue, Farahabad Street</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816135987</zip>
        <telephone>+98 11 3336 1762</telephone>
        <email>marsazaroody@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marsa Zaroudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Left side building, Safarabad  12 Avenue, Farahabad Street</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816135987</zip>
        <telephone>+98 11 3336 1762</telephone>
        <email>marsazaroody@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>50 to 69 years of age
Body mass index equal to and greater than 25 to 40
Blood pressure under control (lower than 140/90 mmHg) in the last two months
The score of a brief cognitive screening test (Mini-Cog) lower or equal of 2
Daily consumption of yogurt at least one serving
Education level of at least five classes
Hb-A1c equal to and less than 8.5
Type 2 diabetes (at least two years)
Willingness to cooperate</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>69 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Immune deficiency diseases
Stage three and above of Chronic Kidney Disease (CKD)
History of heart attack, congestive heart failure, stent placement
Chronic Obstructive Pulmonary Disease (COPD)
Stage three and above of fatty liver
Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), pernicious anemia and mal-absorption such as celiac disease and chronic pancreatitis
Hypothalamic tumor
Uncontrolled thyroid disease
Parathyroid disease
Adrenal disease
Gum surgery under the supervision of a dentist
Gastrointestinal surgeries
Less than two years recovering from cancer
Less than 3 months recovering from Covid-19
Neurological diseases such as seizures, mental retardation and stroke
Comorbid psychiatric disorder such as Generalized Anxiety Disorder (GAD), depression, schizophrenia, dementia, Parkinson's Diseases, and bipolar
Allergy
Uncontrolled hypertriglyceridemia
Allergy to cow's milk protein
lactose intolerance
Taking any medication other than oral medications for diabetes, blood pressure, dyslipidemia, aspirin, and levothyroxine in the last two months
Taking antibiotics
Having a special diet
Regular consumption of dietary supplements (equal to or more than 3 times a week) other than vitamin D during the two months before the study
alcohol consumption
smoking
Being pregnant or breastfeeding
Participating in other medical studies</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The first intervention group: they receive one probiotic supplement capsule + 200 grams of plain yogurt per day for 12 weeks. Probiotic supplement is produced by Takgene Zist Company. This probiotic product is produced from two groups of bacteria, including Lactobacilli and Bifidobacteria, with a dose of two times ten to the power of eight Colony Forming Units (CFU) per capsule, and lactose and magnesium stearate are used as carriers. Plain yogurt is low-fat and produced by Amol Doosheh Dairy Products company. Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of plain yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. The people participating in the study are emphasized to store the yogurts immediately in the refrigerator.</i_keyword>
      <i_keyword>Intervention group: The second intervention group: they will receive 200 grams of probiotic yogurt + one placebo capsule per day for 12 weeks. The probiotic yogurt of the present study is low-fat yogurt and it is produced by Amol Doosheh Dairy Products company. This probiotic product is produced from two groups of bacteria, including Lactobacilli and bifidobacteria, with a dose of two times ten to the power of eight Colony Forming Units (CFU). Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of probiotic yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. Participants are emphasized to store the yogurts immediately in the refrigerator. The placebo capsule is produced by Takgene Zist Company, which contains starch and is similar to the probiotic supplement in terms of appearance, color, size, and packaging.</i_keyword>
      <i_keyword>Control group: they will receive 200 grams of plain yogurt + one placebo capsule per day for 12 weeks. Plain yogurt is low-fat and produced by Amol Doosheh Dairy Products company. Yogurt is distributed weekly, which is provided to the participants in packages containing 14 glasses of 100 grams. Each 100 gram package of plain yogurt contains 51% calories, 3.6 grams of protein, 6 grams of carbohydrates and 1.4 grams of fat. Yogurt packages are delivered to the participants by maintaining the cold chain and at a temperature of minus 4 degrees Celsius. Participants are emphasized to store the yogurts immediately in the refrigerator. The placebo capsule is produced by Takgene Zist Company, which contains starch and is similar to the probiotic supplement in terms of appearance, color, size, and packaging.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of the brief cognitive screening test (Mini-cog). Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (end of week 12). Method of measurement: Mini-cog, a brief cognitive screening test.</prim_outcome>
      <prim_outcome>The score of Stroop color-word. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (end of week 12). Method of measurement: Stroop color-word test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Salivary cortisol. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (end of week 12). Method of measurement: Immunoassay kit.</sec_outcome>
      <sec_outcome>Superoxide Dismutase (SOD). Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (end of week 12). Method of measurement: ELISA kit.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-14</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Faculty of Health, Iran University of Medical Sciences, Hemat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
